See the DrugPatentWatch profile for ozempic

Ozempic, also known as semaglutide, is a medication primarily used to treat type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which work by mimicking the functions of natural hormones in your body to control blood sugar levels [1].

In addition to its use in type 2 diabetes management, Ozempic has also been approved by the U.S. Food and Drug Administration (FDA) for treating obesity in adults with a body mass index (BMI) of 30 or greater, or 27 or greater in the presence of at least one weight-related condition, such as high blood pressure, high cholesterol, or type 2 diabetes [1].

It is important to note that while Ozempic can help manage blood sugar levels and promote weight loss, it is not a first-line treatment for either condition. Lifestyle modifications, such as a healthy diet and regular exercise, are typically recommended before starting medication [1].

Sources:
[1] DrugPatentWatch.com. (n.d.). Ozempic (semaglutide) - DrugPatentWatch. Retrieved from https://www.drugpatentwatch.com/drugs/ozempic